Pivotal Therapeutics
Pivotal Therapeutics is a publicly traded (CNSX: PVO) specialty pharmaceutical company with a focus on the treatment of cardiovascular diseases. Pivotal’s innovative and proprietary lead product, VASCAZENTM, is a prescription grade, ultra-pure Omega 3 fatty acid for the dietary management of cardiovascular disease in patients manifesting an Omega 3 fatty acid deficiency.
Pivotal Therapeutics is a publicly traded (CNSX: PVO)
specialty pharmaceutical company with a focus on the treatment of
cardiovascular diseases. Pivotal’s innovative and proprietary lead product,
VASCAZENTM, is a prescription grade, ultra-pure Omega 3 fatty acid
for the dietary management of cardiovascular disease in patients manifesting an
Omega 3 fatty acid deficiency.
